About: Bio-Israel

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam libero diam, elementum eget porttitor at, tincidunt at nulla.

Recent Posts by Bio-Israel

Medicortex Crowdfunding Campaign for Brain Injury Detection Kit

Medicortex has launched a crowdfunding campaign in order to generate support for developing a diagnostic kit for brain injury detection. The target is 200,000 Euro with a maximum of 560,000 Euro offering equity of between 4.76 and 12.28 percent. The price per share is 4 Euro with a minimum investment...
Read more

BioLineRX Acquires Agalimmune

BioLineRx has acquired Agalimmune Ltd., a private UK-based company with an innovative, anti-cancer immunotherapy platform. Acquisition consideration consisted of a $6 million upfront payment, of which $3 million is in cash and the remainder in BioLineRx shares. Additional future payments may be made based on development and commercial milestones. Agalimmune’s...
Read more

FDA Approval for Cervical Cancer Device

The U.S. Food and Drug Administration approved Mobile ODT’s EVA (Enhanced Visual Assessment) System for marketing and sale in the United States. The tragedy of cervical cancer – strongly addressed in major urban areas – still plagues much of America, where it is increasingly difficult for a woman to get...
Read more

New Compugen Immune Checkpoint

Compugen Ltd. (NASDAQ: CGEN) announced development of CGEN-15137, its cancer immunotherapy program for TIGIT. TIGIT is an immune checkpoint in the B7/CD28 family which has recently gained broad industry interest in the field of immuno-oncology. At the recent Annual Meeting of the Society for Immunotherapy of Cancer, the company disclosed...
Read more

BioSight Success in Leukemia Trial

Cancer treatment company BioSight, which recently received a $13 million investment from Mori Arkin and US investment fund Primera Capital, reports positive interim results of an initial efficacy trial for its Leukemia treatment product. The company’s product, Astarabine, had been tested on 15 Acute Myeloid Leukemia (AML) and Acute Lymphoblastic...
Read more

Recent Comments by Bio-Israel

    No comments by Bio-Israel yet.